Inventor · disambiguated record
Charles Conway
Also filed as: CONWAY CHARLES · CONWAY CHARLES M · CONWAY CHARLES MARK
4 granted patents·8 pending applications·30 citations·filing 2001–2022
71Inventor score
Files withBIOHAVEN PHARM HOLDING CO LTD3PFIZER IRELAND PHARMACEUTICALS3BRISTOL MYERS SQUIBB CO2UNION PHARMA SCIENT APPL2BIOHAVEN PHARMACEUTICAL IRELAND DAC1
Top patents by PatentIndex Score
12 records- 0182US6593331B2Method for treatment of painUNION PHARMA SCIENT APPL·Filed 2002·Granted Jul 15, 2003·22 cites·22 claims
- 0271US6566361B2Azapirone pain treatmentUNION PHARMA SCIENT APPL·Filed 2001·Granted May 20, 2003·5 cites·26 claims
- 0363US6511982B2Treatment of painBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Jan 28, 2003·3 cites·26 claims
- 0454US2023285380A1Dual treatment of migraineBIOHAVEN PHARMACEUTICAL IRELAND DAC·Filed 2022·Application pending·0 cites
- 0553US2024066028A1Compositions for improved delivery of cgrp inhibitorsPFIZER IRELAND PHARMACEUTICALS·Filed 2021·Application pending·0 cites
- 0653US2024408080A1Pharmaceutical compositions of cgrp inhibitors and methods of their usePFIZER IRELAND PHARMACEUTICALS·Filed 2022·Application pending·0 cites
- 0751US12030868B2Prodrugs of CGRP antagonistsPFIZER IRELAND PHARMACEUTICALS·Filed 2019·Granted Jul 9, 2024·0 cites·20 claims
- 0851US2023285390A1Methods of treating pulmonary injury with cgrp inhibitorsBIOHAVEN PHARM HOLDING CO LTD·Filed 2021·Application pending·0 cites
- 0950US2022401439A1Intranasal pharmaceutical compositions of cgrp inhibitorsBIOHAVEN PHARM HOLDING CO LTD·Filed 2020·Application pending·0 cites
- 1050US2023108049A1Oral fast-dispersing dosage form of rimegepantBIOHAVEN PHARM HOLDING CO LTD·Filed 2021·Application pending·0 cites
- 1147US2004063735A1Calcitonin gene related peptide receptor antagonistsFiled 2003·Application pending·0 cites
- 1247US2007148093A1Non-terminal method of identifying anti-migraine compoundsBRISTOL MYERS SQUIBB CO·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Charles Conway files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →